CYD Stock Analysis: China Yuchai International | NYSE
Auto Manufacturers | NYSE, USA | Market Cap: 1.199m USD | 12M Return: -19.4% | BMG210821051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.17M
Qual. Beats: 0
Rev. Trend: 71.3%
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
China Yuchai International (NYSE: CYD) is a Singapore-headquartered engine manufacturer producing diesel and natural gas powertrains for trucks, buses, pickups, agricultural and construction equipment, and marine and power-generation applications.
The company reports through two segments: Yuchai, its core on- and off-road powertrain business, and HLGE, which conducts hospitality and property development activities-a diversification unusual within the Chinese heavy-duty engine industry, where peers typically focus narrowly on powertrain and components.
CYDs product range includes four- and six-cylinder diesel engines, high-horsepower marine and genset units, and a broadening lineup of alternative-fuel and electrified drivetrains such as natural gas, methanol, and hydrogen combustion engines, plug-in hybrid systems, range extenders, electric drive axles, and fuel cell systems-reflecting the commercial-vehicle sectors transition toward lower-emission propulsion in line with Chinese emissions and decarbonization policy.
Products are sold directly to OEMs, agents, and retailers in the Peoples Republic of China and in international markets. Founded in 1951, Yuchai has been listed on the NYSE since December 1994 and is classified within the Industrials sector under construction machinery and heavy transportation equipment.
- China commercial truck and bus engine demand weakens
- Natural gas engine adoption accelerates on emissions policy
- New energy powertrain ramp pressures legacy diesel margins
- HLGE hospitality and property segment continues to drag earnings
| Net Income: 1.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 6.48 > 1.0 |
| NWC/Revenue: 33.02% < 20% (prev 72.60%; Δ -39.58% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.72b > Net Income 1.07b |
| Net Debt (-6.60b) to EBITDA (2.33b): -2.83 < 3 |
| Current Ratio: 2.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.9m) vs 12m ago 0.16% < -2% |
| Gross Margin: 17.46% > 18% (prev 13.57%; Δ 3.89% > 0.5%) |
| Asset Turnover: 167.5% > 50% (prev 72.79%; Δ 94.70% > 0%) |
| Interest Coverage Ratio: 16.06 > 6 (EBIT TTM 1.62b / Interest Expense TTM 100.9m) |
| A: 0.53 (Total Current Assets 27.9b - Total Current Liabilities 13.2b) / Total Assets 27.9b |
| B: 0.25 (Retained Earnings 6.95b / Total Assets 27.9b) |
| C: 0.06 (EBIT TTM 1.62b / Avg Total Assets 26.6b) |
| D: 0.69 (Book Value of Equity 10.2b / Total Liabilities 14.6b) |
| Altman-Z'' = 5.41 = AAA |
| DSRI: 0.46 (Receivables 14.1b/12.7b, Revenue 44.5b/18.4b) |
| GMI: 0.78 (GM 13.57% / 17.46%) |
| AQI: 0.94 (AQ_t -0.14 / AQ_t-1 -0.15) |
| SGI: 2.42 (Revenue 44.5b / 18.4b) |
| TATA: -0.06 (NI 1.07b - CFO 2.72b) / TA 27.9b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of October 11, 2026, the stock is trading at USD 29.82 with a total of 348,046 shares traded. Over the past week, the price has changed by -6.67%, over one month by -19.90%, over three months by -35.39% and over the past year by -19.42%.
Current recommended Stop Loss: 27.60 (which is 7.4% or 1.2 ATR below the current price).
China Yuchai International has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy CYD.
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 59.1 | 98.2% |
Market Cap CNY = 8.02b (1.20b USD * 6.692 USD.CNY)
P/E Trailing = 11.0554
P/E Forward = 9.1743
P/S = 0.0453
P/B = 0.8558
P/EG = 0.3721
Revenue TTM = 44.5b CNY
EBIT TTM = 1.62b CNY
EBITDA TTM = 2.33b CNY
Long Term Debt = 20.0m CNY (from longTermDebt, last fiscal year)
Short Term Debt = 2.04b CNY (from shortTermDebt, last fiscal year)
Debt = 1.51b CNY (from shortLongTermDebtTotal, last quarter) + Leases 77.7m
Net Debt = -6.60b CNY (calculated: Debt 1.51b - CCE 8.10b)
Enterprise Value = 1.43b CNY (8.02b + Debt 1.51b - CCE 8.10b)
Interest Coverage Ratio = 16.06 (Ebit TTM 1.62b / Interest Expense TTM 100.9m)
EV/FCF = 0.69x (Enterprise Value 1.43b / FCF TTM 2.07b)
FCF Yield = 144.9% (FCF TTM 2.07b / Enterprise Value 1.43b)
FCF Margin = 4.64% (FCF TTM 2.07b / Revenue TTM 44.5b)
Net Margin = 2.41% (Net Income TTM 1.07b / Revenue TTM 44.5b)
Gross Margin = 17.46% ((Revenue TTM 44.5b - Cost of Revenue TTM 36.8b) / Revenue TTM)
Gross Margin QoQ = 17.12% (prev 18.91%)
Tobins Q-Ratio = 0.05 (Enterprise Value 1.43b / Total Assets 27.9b)
Interest Expense / Debt = 6.69% (Interest Expense 100.9m / Debt 1.51b)
Taxrate = 29.60% (690.1m / 2.33b)
NOPAT = 1.14b (EBIT 1.62b * (1 - 29.60%))
Current Ratio = 2.11 (Total Current Assets 27.9b / Total Current Liabilities 13.2b)
Debt / Equity = 0.15 (Debt 1.51b / totalStockholderEquity, last quarter 10.2b)
Debt / EBITDA = -2.83 (Net Debt -6.60b / EBITDA 2.33b)
Debt / FCF = -3.19 (Net Debt -6.60b / FCF TTM 2.07b)
Total Stockholder Equity = 9.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 1.07b / Total Assets 27.9b)
RoE = 11.10% (Net Income TTM 1.07b / Total Stockholder Equity 9.68b)
RoCE = 16.70% (EBIT 1.62b / Capital Employed (Equity 9.68b + L.T.Debt 20.0m))
RoIC = 7.86% (NOPAT 1.14b / Invested Capital 14.5b)
WACC = 9.96% (E(8.02b)/V(9.53b) * Re(10.95%) + D(1.51b)/V(9.53b) * Rd(6.69%) * (1-Tc(0.30)))
Discount Rate = 10.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -81.04 | Cagr: -3.34%
[DCF] Terminal Value 72.94% ; FCFF base≈1.33b ; Y1≈1.53b ; Y5≈2.25b
[DCF] Fair Price = 878.5 (EV 26.4b - Net Debt -6.60b = Equity 33.0b / Shares 37.5m; r=9.96% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 71.26 | Revenue CAGR: 30.89% | SUE: N/A | # QB: 0
EPS current Year (2025-12-31): EPS=16.95 | Chg30d=+6.42% | Revisions=+25% | GrowthEPS=+106.5% | GrowthRev=+38.1%
EPS next Year (2026-12-31): EPS=22.93 | Chg30d=-0.27% | Revisions=+17% | GrowthEPS=+60.1% | GrowthRev=+13.3%
[Analyst] Revisions Ratio: +29% (up=3, down=1)